Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction
Catch up on this on-demand webinar to learn about early and late-onset neonatal hypocalcemia diagnosis
The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics
In this guest article by RayBiotech Life, learn how to easily obtain IHC positive controls for different pathologies without the need for patient samples
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
Discover how to increase precision and reduce throughput time of your routine electrolyte analyses
Learn how COVID-19 serology testing may inform long-term vaccination strategy and influence short-term prioritization and delivery
Infectious disease expert shares how robust LC columns are facilitating the analysis of complex pathogen samples
Dr. Frank Peacock discusses the impact of delayed care in the ED setting, the power of high-sensitivity troponin assays, and the value of point of care
Labs processing 2,000 to 5,000 tests a day can finally enjoy the benefits of Total Laboratory Automation (TLA) with a compact workflow-automation solution that fits needs
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology
Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated
COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study
A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics
Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse
